(19)
(11) EP 4 017 521 A1

(12)

(43) Date of publication:
29.06.2022 Bulletin 2022/26

(21) Application number: 20761856.2

(22) Date of filing: 01.09.2020
(51) International Patent Classification (IPC): 
A61K 38/37(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 38/00; A61P 7/04; C07K 14/755
(86) International application number:
PCT/EP2020/074326
(87) International publication number:
WO 2021/043757 (11.03.2021 Gazette 2021/10)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 02.09.2019 EP 19194964
11.10.2019 EP 19202622

(71) Applicant: Biotest AG
63303 Dreieich (DE)

(72) Inventors:
  • KISTNER, Steffen
    60599 Frankfurt/Main (DE)
  • SCHÜTTRUMPF, Jörg
    63303 Dreieich (DE)
  • DAUFENBACH, Jens
    55120 Mainz (DE)
  • HERBENER, Peter
    35274 Kirchhain (DE)
  • UNGERER, Christopher
    63225 Langen (DE)
  • DE GROOT, Annie
    Providence, RI 02909 (US)
  • MARTIN, William
    Providence, RI 02909 (US)

(74) Representative: Moré, Solveig Helga et al
Kroher Strobel Rechts- und Patentanwälte PartmbB Bavariaring 20
80336 München
80336 München (DE)

   


(54) FACTOR VIII PROTEIN WITH INCREASED HALF-LIFE